The majority of patients with type 2 diabetes and obesity have insulin resistance in their muscles, liver, and fat, which reduces these tissues' sensitivity to insulin [3].Given the rising prevalence of type 2 diabetes and its association with glucocorticoid use, understanding the underlying mechanisms and potential intervention is crucial. The gene discussed is INS; the disease is Insulin resistance.